FzioMed: Creators of Oxiplex

News Releases

December 12, 2005	FzioMed Submits Third PMA Module to The U.S. Food & Drug Administration for Oxiplex/SP Spine Gel
November 28, 2005	FzioMed Announces Publication in Fertility & Sterility Journal of Positive Clinical Results from Oxiplex/AP U.S. Trial in Adhesion Prevention
November 15, 2005	FzioMed Receives NIH Grant to Study Injectable Delivery of Bone Growth Peptides for Spinal Fusion
November 10, 2005	FzioMed Announces Exclusive, Worldwide License for Bone Growth Peptide Portfolio
October 19, 2005	FzioMed Appoints Ron Ehmsen as Vice President of Clinical Affairs
September 28, 2005	FzioMed Presents Preclinical Studies of Oxiplex Gel for Drug Delivery, Including Results of Novel Bone Growth Factor
September 14, 2005	FzioMed Announces Positive Clinical Results Using Oxiplex/AP to Prevent Post-Surgical Adhesions in Endometriosis Patients
August 11 , 2005	FzioMed Granted Patent Expanding Oxiplex ® Technology in Drug Delivery and Hemostasis
July 19, 2005	FzioMed Appoints John S. Krelle as President and Chief Operating Officer
July 6, 2005	FzioMed Reports Promising Results of Novel Bone Growth Factor in Preclinical Studies and Demonstrates Oxiplex Gel as Effective Drug Delivery Platform
June 16, 2005	FzioMed and Ethicon Sign Exclusive Distribution Agreement for Adhesion Barrier Product
April 11, 2005	FzioMed Awarded New U.S. Patent For Oxiplex® Biomaterial Technology

Archives 2007 2006 2005 2004 2003 2002 2001 2000

Site designed by New Image Technologies, Inc.